CDKN2B and colorectal carcinoma: In Tokugunaga et al., the loss of the JMJD3 was considered a marker of poor prognosis in CRC and promoted cell proliferation, suppression of apoptosis, and reduction in the expression of the p15INK4b tumor suppressor [81].